Observational studyClinical pharmacokinetics2026

Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis.

Trond Trætteberg Serkland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.